[KSCI] Korea Science Citation Index Service

http://dx.doi.org/10.5483/BMBRep.2014.47.2.005

Exploiting tumor cell senescence in anticancer therapy

Lee, Minyoung (Research Center for Radio-senescence, Korea Institute of Radiological and Medical Sciences)
Lee, Jae-Seon (Research Center for Radio-senescence, Korea Institute of Radiological and Medical Sciences)

Publication Information

BMB Reports / v.47, no.2, 2014 , pp. 51-59 More about this Journal

Abstract

Cellular senescence is a physiological process of irreversible cell-cycle arrest that contributes to various physiological and pathological processes of aging. Whereas replicative senescence is associated with telomere attrition after repeated cell division, stress-induced premature senescence occurs in response to aberrant oncogenic signaling, oxidative stress, and DNA damage which is independent of telomere dysfunction. Recent evidence indicates that cellular senescence provides a barrier to tumorigenesis and is a determinant of the outcome of cancer treatment. However, the senescence-associated secretory phenotype, which contributes to multiple facets of senescent cancer cells, may influence both cancer-inhibitory and cancer-promoting mechanisms of neighboring cells. Conventional treatments, such as chemo- and radiotherapies, preferentially induce premature senescence instead of apoptosis in the appropriate cellular context. In addition, treatment-induced premature senescence could compensate for resistance to apoptosis via alternative signaling pathways. Therefore, we believe that an intensive effort to understand cancer cell senescence could facilitate the development of novel therapeutic strategies for improving the efficacy of anticancer therapies. This review summarizes the current understanding of molecular mechanisms, functions, and clinical applications of cellular senescence for anticancer therapy.

Keywords

Anticancer therapy; Cellular senescence; Tumorigenesis; SASP;

Citations & Related Records

Reference

1	Wadhwa, R., Sugihara, T., Taira, K. and Kaul, S. C. (2004) The ARF-p53 senescence pathway in mouse and human cells. Histol. Histopathol. 19, 311-316.
2	Parrinello, S., Coppe, J. P., Krtolica, A. and Campisi, J. (2005) Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118, 485-496. DOI ScienceOn
3	Salminen, A., Kauppinen, A. and Kaarniranta, K. (2012) Emerging role of NF-kappaB signaling in the induction of senescence-associated secretory phenotype (SASP). Cell Signal. 24, 835-845. DOI ScienceOn
4	Coppe, J. P., Kauser, K., Campisi, J. and Beausejour, C. M. (2006) Secretion of vascular endothelial growth factor by primary human fibroblasts at senescence. J. Biol. Chem. 281, 29568-29574. DOI ScienceOn
5	Gosselin, K., Martien, S., Pourtier, A., Vercamer, C., Ostoich, P., Morat, L., Sabatier, L., Duprez, L., T'Kint de Roodenbeke, C., Gilson, E., Malaquin, N., Wernert, N., Slijepcevic, P., Ashtari, M., Chelli, F., Deruy, E., Vandenbunder, B., De Launoit, Y. and Abbadie, C. (2009) Senescence-associated oxidative DNA damage promotes the generation of neoplastic cells. Cancer Res. 69, 7917-7925. DOI ScienceOn
6	Acosta, J. C., O'Loghlen, A., Banito, A., Raguz, S. and Gil, J. (2008) Control of senescence by CXCR2 and its ligands. Cell Cycle 7, 2956-2959. DOI
7	Bavik, C., Coleman, I., Dean, J. P., Knudsen, B., Plymate, S. and Nelson, P. S. (2006) The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res. 66, 794-802. DOI ScienceOn
8	Sagiv, A. and Krizhanovsky, V. (2013) Immunosurveillance of senescent cells: the bright side of the senescence program. Biogerontology. 14, 617-628. DOI ScienceOn
9	Mariotti, M., Castiglioni, S., Bernardini, D. and Maier, J. A. (2006) Interleukin 1 alpha is a marker of endothelial cellular senescent. Immun. Ageing 3, 4. DOI ScienceOn
10	Orjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K. and Campisi, J. (2009) Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc. Natl. Acad. Sci. U. S. A. 106, 17031-17036. DOI ScienceOn
11	Novakova, Z., Hubackova, S., Kosar, M., Janderova- Rossmeislova, L., Dobrovolna, J., Vasicova, P., Vancurova, M., Horejsi, Z., Hozak, P., Bartek, J. and Hodny, Z. (2010) Cytokine expression and signaling in drug-induced cellular senescence. Oncogene 29, 273-284. DOI ScienceOn
12	Coppe, J. P., Patil, C. K., Rodier, F., Sun, Y., Munoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P. Y. and Campisi, J. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868.
13	Puche, J. E. and Castilla-Cortazar, I. (2012) Human conditions of insulin-like growth factor-I (IGF-I) deficiency. J. Transl. Med. 10, 224. DOI
14	Lopez-Bermejo, A., Buckway, C. K., Devi, G. R., Hwa, V., Plymate, S. R., Oh, Y. and Rosenfeld, R. G. (2000) Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. Endocrinology 141, 4072-4080. DOI
15	Tsai, K. K., Chuang, E. Y., Little, J. B. and Yuan, Z. M. (2005) Cellular mechanisms for low-dose ionizing radiation- induced perturbation of the breast tissue microenvironment. Cancer Res. 65, 6734-6744. DOI ScienceOn
16	Maki, R. G. (2010) Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. J. Clin. Oncol. 28, 4985-4995. DOI ScienceOn
17	Wang, S., Moerman, E. J., Jones, R. A., Thweatt, R. and Goldstein, S. (1996) Characterization of IGFBP-3, PAI-1 and SPARC mRNA expression in senescent fibroblasts. Mech. Ageing. Dev. 92, 121-132. DOI ScienceOn
18	Liu, D. and Hornsby, P. J. (2007) Senescent human fibroblasts increase the early growth of xenograft tumors via matrix metalloproteinase secretion. Cancer Res. 67, 3117-3126. DOI ScienceOn
19	Dass, K., Ahmad, A., Azmi, A. S., Sarkar, S. H. and Sarkar, F. H. (2008) Evolving role of uPA/uPAR system in human cancers. Cancer Treat. Rev. 34, 122-136. DOI ScienceOn
20	Hornebeck, W. and Maquart, F. X. (2003) Proteolyzed matrix as a template for the regulation of tumor progression. Biomed. Pharmacother. 57, 223-230. DOI ScienceOn
21	Schadendorf, D., Moller, A., Algermissen, B., Worm, M., Sticherling, M. and Czarnetzki, B. M. (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor. J. Immunol. 151, 2667-2675.
22	Norgauer, J., Metzner, B. and Schraufstatter, I. (1996) Expression and growth-promoting function of the IL-8 receptor beta in human melanoma cells. J. Immunol. 156, 1132-1137.
23	Laberge, R. M., Awad, P., Campisi, J. and Desprez, P. Y. (2012) Epithelial-mesenchymal transition induced by senescent fibroblasts. Cancer Microenviron. 5, 39-44. DOI ScienceOn
24	Ksiazek, K., Jorres, A. and Witowski, J. (2008) Senescence induces a proangiogenic switch in human peritoneal mesothelial cells. Rejuvenation. Res. 11, 681-683. DOI ScienceOn
25	Chaturvedi, S. and Hass, R. (2011) Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development. Mech. Ageing. Dev. 132, 213-219. DOI ScienceOn
26	Studebaker, A. W., Storci, G., Werbeck, J. L., Sansone, P., Sasser, A. K., Tavolari, S., Huang, T., Chan, M. W., Marini, F. C., Rosol, T. J., Bonafe, M. and Hall, B. M. (2008) Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res. 68, 9087-9095. DOI ScienceOn
27	Smit, M. A. and Peeper, D. S. (2010) Epithelial-mesenchymal transition and senescence: two cancer-related processes are crossing paths. Aging (Albany NY) 2, 735-741.
28	Sica, A., Schioppa, T., Mantovani, A. and Allavena, P. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727. DOI ScienceOn
29	Han, N. K., Kim, B. C., Lee, H. C., Lee, Y. J., Park, M. J., Chi, S. G., Ko, Y. G. and Lee, J. S. (2012) Secretome analysis of ionizing radiation-induced senescent cancer cells reveals that secreted RKIP plays a critical role in neighboring cell migration. Proteomics 12, 2822-2832. DOI ScienceOn
30	Nardella, C., Clohessy, J. G., Alimonti, A. and Pandolfi, P. P. (2011) Pro-senescence therapy for cancer treatment. Nat. Rev. Cancer 11, 503-511. DOI ScienceOn
31	Acosta, J. C. and Gil, J. (2012) Senescence: a new weapon for cancer therapy. Trends. Cell Biol. 22, 211-219. DOI ScienceOn
32	Ewald, J. A., Desotelle, J. A., Wilding, G. and Jarrard, D. F. (2010) Therapy-induced senescence in cancer. J. Natl. Cancer Inst. 102, 1536-1546. DOI ScienceOn
33	Schwarze, S. R., Fu, V. X., Desotelle, J. A., Kenowski, M. L. and Jarrard, D. F. (2005) The identification of senescence- specific genes during the induction of senescence in prostate cancer cells. Neoplasia 7, 816-823. DOI ScienceOn
34	Asai, A., Oshima, Y., Yamamoto, Y., Uochi, T. A., Kusaka, H., Akinaga, S., Yamashita, Y., Pongracz, K., Pruzan, R., Wunder, E., Piatyszek, M., Li, S., Chin, A. C., Harley, C. B. and Gryaznov, S. (2003) A novel telomerase template antagonist (GRN163) as a potential anticancer agent. Cancer Res. 63, 3931-3939.
35	Rebbaa, A., Zheng, X., Chu, F. and Mirkin, B. L. (2006) The role of histone acetylation versus DNA damage in drug-induced senescence and apoptosis. Cell. Death. Differ. 13, 1960-1967. DOI ScienceOn
36	Nardella, C., Clohessy, J. G., Alimonti, A. and Pandolfi, P. P. (2011) Pro-senescence therapy for cancer treatment. Nature. Rev. Cancer 11, 503-511. DOI ScienceOn
37	Lee, J. J., Kim, B. C., Park, M. J., Lee, Y. S., Kim, Y. N., Lee, B. L. and Lee, J. S. (2011) PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation. Cell Death. Differ. 18, 666-677. DOI ScienceOn
38	Bykov, V. J., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G. and Selivanova, G. (2002) Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nat. Med. 8, 282-288. DOI ScienceOn
39	Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R. and Jacks, T. (2007) Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661-665. DOI ScienceOn
40	Martinkova, E., Maglott, A., Leger, D. Y., Bonnet, D., Stiborova, M., Takeda, K., Martin, S. and Dontenwill, M. (2010) alpha5beta1 integrin antagonists reduce chemotherapy- induced premature senescence and facilitate apoptosis in human glioblastoma cells. Int. J. Cancer 127, 1240-1248. DOI ScienceOn
41	Michaloglou, C., Vredeveld, L. C., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M., Majoor, D. M., Shay, J. W., Mooi, W. J. and Peeper, D. S. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436, 720-724. DOI ScienceOn
42	Alimonti, A., Nardella, C., Chen, Z., Clohessy, J. G., Carracedo, A., Trotman, L. C., Cheng, K., Varmeh, S., Kozma, S. C., Thomas, G., Rosivatz, E., Woscholski, R., Cognetti, F., Scher, H. I. and Pandolfi, P. P. (2010) A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis. J. Clin. Invest. 120, 681-693. DOI ScienceOn
43	Campisi, J. (1996) Replicative senescence: an old lives' tale? Cell 84, 497-500. DOI ScienceOn
44	Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., Chesi, M., Schinzel, A. C., McKeown, M. R., Heffernan, T. P., Vakoc, C. R., Bergsagel, P. L., Ghobrial, I. M., Richardson, P. G., Young, R. A., Hahn, W. C., Anderson, K. C., Kung, A. L., Bradner, J. E. and Mitsiades, C. S. (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146, 904-917. DOI ScienceOn
45	Lee, J. J., Lee, J. H., Ko, Y. G., Hong, S. I. and Lee, J. S. (2010) Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species. Oncogene 29, 561-575. DOI ScienceOn
46	Kim, B. C., Lee, H. C., Lee, J. J., Choi, C. M., Kim, D. K., Lee, J. C., Ko, Y. G. and Lee, J. S. (2012) Wig1 prevents cellular senescence by regulating p21 mRNA decay through control of RISC recruitment. EMBO J. 31, 4289-4303. DOI
47	Chen, Z., Trotman, L. C., Shaffer, D., Lin, H. K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., Cordon-Cardo, C. and Pandolfi, P. P. (2005) Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436, 725-730. DOI ScienceOn
48	Efeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T. and Serrano, M. (2007) Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin. Cancer Res. 67, 7350-7357. DOI ScienceOn
49	Toussaint, O., Medrano, E. E. and von Zglinicki, T. (2000) Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Exp. Gerontol. 35, 927-945. DOI ScienceOn
50	Deng, Y. and Chang, S. (2007) Role of telomeres and telomerase in genomic instability, senescence and cancer. Lab. Invest. 87, 1071-1076. DOI ScienceOn
51	Gorgoulis, V. G. and Halazonetis, T. D. (2010) Oncogene-induced senescence: the bright and dark side of the response. Curr. Opin. Cell. Biol. 22, 816-827. DOI ScienceOn
52	Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. and Lowe, S. W. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602. DOI ScienceOn
53	Shamma, A., Takegami, Y., Miki, T., Kitajima, S., Noda, M., Obara, T., Okamoto, T. and Takahashi, C. (2009) Rb Regulates DNA damage response and cellular senescence through E2F-dependent suppression of N-ras isoprenylation. Cancer Cell 15, 255-269. DOI ScienceOn
54	Suzuki, M. and Boothman, D. A. (2008) Stress-induced premature senescence (SIPS)--influence of SIPS on radiotherapy. J. Radiat. Res. 49, 105-112. DOI ScienceOn
55	Young, A. R. and Narita, M. (2009) SASP reflects senescence. EMBO Rep. 10, 228-230. DOI ScienceOn
56	Gewirtz, D. A., Holt, S. E. and Elmore, L. W. (2008) Accelerated senescence: an emerging role in tumor cell response to chemotherapy and radiation. Biochem. Pharmacol. 76, 947-957. DOI ScienceOn
57	Davalos, A. R., Coppe, J. P., Campisi, J. and Desprez, P. Y. (2010) Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis. Rev. 29, 273-283. DOI ScienceOn
58	Campisi, J. (2013) Aging, cellular senescence, and cancer. Annu. Rev. Physiol. 75, 685-705. DOI ScienceOn
59	Campisi, J., Andersen, J. K., Kapahi, P. and Melov, S. (2011) Cellular senescence: a link between cancer and age-related degenerative disease? Semin. Cancer Biol. 21, 354-359.
60	Coppe, J. P., Desprez, P. Y., Krtolica, A. and Campisi, J. (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5, 99-118. DOI ScienceOn
61	de Magalhaes, J. P. (2013) How ageing processes influence cancer. Nat. Rev. Cancer 13, 357-365. DOI ScienceOn
62	Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. and Kroemer, G. (2013) The hallmarks of aging. Cell 153, 1194-1217. DOI ScienceOn
63	Oyama, K., Okawa, T., Nakagawa, H., Takaoka, M., Andl, C. D., Kim, S. H., Klein-Szanto, A., Diehl, J. A., Herlyn, M., El-Deiry, W. and Rustgi, A. K. (2007) AKT induces senescence in primary esophageal epithelial cells but is permissive for differentiation as revealed in organotypic culture. Oncogene 26, 2353-2364. DOI ScienceOn
64	Dhomen, N., Reis-Filho, J. S., da Rocha Dias, S., Hayward, R., Savage, K., Delmas, V., Larue, L., Pritchard, C. and Marais, R. (2009) Oncogenic Braf induces melanocyte senescene and melanoma in mice. Cancer Cell 15, 294-303. DOI ScienceOn
65	Collado, M., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguria, A., Zaballos, A., Flores, J. M., Barbacid, M., Beach, D. and Serrano, M. (2005) Tumor biology: senescence in premalignant tumors. Nature 436, 642. DOI ScienceOn
66	Kuilman, T., Michaloglou, C., Mooi, W. J. and Peeper, D. S. (2010) The essence of senescence. Genes Dev. 24, 2463-2479. DOI ScienceOn
67	Wennmalm, K., Wahlestedt, C. and Larsson, O. (2005) The expression signature of in vitro senescence resembles mouse but not human aging. Genome. Biol. 6, R109. DOI
68	Canpo-Trapero, J., Cano-Sanchez, J., Palacios-Sanchez, B., Llamas-Martinez, S., Lo Muzio, L. and Bascones-Martinez, A. (2008) Cellular senescence in oral cancer and precancer and treatment implications: A review. Acta. Oncologica. 47, 1464-1474. DOI ScienceOn
69	de Magalhaes, J. P., Curado, J. and Church, G. M. (2009) Meta-analysis of age-related gene expression profiles identifies common signatures of aging. Bioinformatics 25, 875-881. DOI ScienceOn
70	Mason, D. X., Jackson, T. J. and Lin, A. W. (2004) Molecular signature of oncogenic ras-induced senescence. Oncogene 23, 9238-9246. DOI
71	Calvanese, V., Lara, E., Kahn, A. and Fraga, M. F. (2009) The role of epigenetics in aging and age-related diseases. Ageing. Res. Rev. 8, 268-276. DOI ScienceOn
72	Larsson, L. G. (2011) Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Semin. Cancer Biol. 21, 367-376.
73	Ohtani, N. and Hara, E. (2013) Roles and mechanisms of cellular senescence in regulation of tissue homeostasis. Cancer Sci. 104, 525-530. DOI ScienceOn
74	Adams, P. D. (2009) Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol. Cell 36, 2-14. DOI ScienceOn
75	Chandler, H. and Peters, G. (2013) Stressing the cell cycle in senescence and aging. Curr. Opin. Cell Biol. 25, 765-771. DOI ScienceOn
76	Carnero, A. and Beach, D. H. (2004) Absence of p21WAF1 cooperates with c-myc in bypassing Ras-induced senescence and enhances oncogenic cooperation. Oncogene 23, 6006-6011. DOI ScienceOn
77	Reinhardt, H. C. and Schumacher, B. (2012) The p53 network: cellular and systemic DNA damage responses in aging and cancer. Trends. Genet. 28, 128-136. DOI ScienceOn
78	Warfel, N. A. and El-Deiry, W. S. (2013) p21WAF1 and tumourigenesis: 20 years after. Curr. Opin. Oncol. 25, 52-58. DOI
79	Roninson, I. B. (2002) Oncogenic functions of tumour suppressor p21(Waf1/Cip1/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts. Cancer Lett. 179, 1-14. DOI ScienceOn
80	Groth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J. and Roussel, M. F. (2000) Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases. J. Biol. Chem. 275, 27473-27480.
81	Pantoja, C. and Serrano, M. (1999) Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras. Oncogene 18, 4974-4982. DOI
82	Dominguez-Brauer, C., Brauer, P. M., Chen, Y. J., Pimkina, J. and Raychaudhuri, P. (2010) Tumor suppression by ARF: gatekeeper and caretaker. Cell Cycle. 9, 86-89. DOI
83	Kim, W. Y. and Sharpless, N. E. (2006) The regulation of INK4/ARF in cancer and aging. Cell 127, 265-275. DOI ScienceOn
84	Rayess, H., Wang, M. B. and Srivatsan, E. S. (2012) Cellular senescence and tumor suppressor gene p16. Int. J. Cancer 130, 1715-1725. DOI ScienceOn
85	Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., Peacocke, M. and Campisi, J. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92, 9363-9367. DOI ScienceOn
86	Kang, T. W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., Iken, M., Vucur, M., Weiss, S., Heikenwalder, M., Khan, S., Gil, J., Bruder, D., Manns, M., Schirmacher, P., Tacke, F., Ott, M., Luedde, T., Longerich, T., Kubicka, S. and Zender, L. (2011) Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479, 547-551. DOI ScienceOn
87	Benanti, J. A. and Galloway, D. A. (2004) The normal response to RAS: senescence or transformation? Cell Cycle. 3, 715-717.
88	Young, A. P., Schlisio, S., Minamishima, Y. A., Zhang, Q., Li, L., Grisanzio, C., Signoretti, S. and Kaelin, W. G. Jr. (2008) VHL loss actuates a HIF-independent senescence programme mediated by Rb and p400. Nat. Cell Biol. 10, 361-369. DOI ScienceOn
89	Efeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T. and Serrano, M. (2007) Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin. Cancer Res. 67, 7350-7357. DOI ScienceOn
90	Ben-Porath, I. and Weinberg, R. A. (2005) The signals and pathways activating cellular senescence. Int. J. Biochem. Cell. Biol. 37, 961-976. DOI ScienceOn
91	Byun, H. O., Han, N. K., Lee, H. J., Kim, K. B., Ko, Y. G., Yoon, G., Lee, Y. S., Hong, S. I. and Lee, J. S. (2009) Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence. Cancer Res. 69, 4638-4647. DOI ScienceOn
92	Indovina, P., Marcelli, E., Casini, N., Rizzo, V. and Giordano, A. (2013) Emerging roles of RB family: new defense mechanisms against tumor progression. J. Cell Physiol. 228, 525-535. DOI ScienceOn
93	Pazolli, E., Luo, X., Brehm, S., Carbery, K., Chung, J. J., Prior, J. L., Doherty, J., Demehri, S., Salavaggione, L., Piwnica-Worms, D. and Stewart, S. A. (2009) Senescent stromal-derived osteopontin promotes preneoplastic cell growth. Cancer Res. 69, 1230-1239. DOI ScienceOn
94	Barcellos-Hoff, M. H. and Ravani, S. A. (2000) Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells. Cancer Res. 60, 1254-1260.
95	Xue, W., Zender, L., Miethng, C., Dickins R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C. and Lowe, S. M. (2007) Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445, 656-660. DOI ScienceOn

Reference

	Anna Maria Mileo. (2015) Oxidative Medicine and Cellular Longevity Long Term Exposure to Polyphenols of Artichoke (Cynara scolymusL.) Exerts Induction of Senescence Driven Growth Arrest in the MDA-MB231 Human Breast Cancer Cell Line / 2015 , 1
3	Jun He. (2016) Anti-Cancer Drugs Oroxin A inhibits breast cancer cell growth by inducing robust endoplasmic reticulum stress and senescence / 27 (3) , 204
6	Christopher S Hong. (2015) Cancer Biology & Therapy LB100, a small molecule inhibitor of PP2A with potent chemo- and radio-sensitizing potential / 16 (6) , 821
2	Florian Foerster. (2016) Bioorganic & Medicinal Chemistry Actin-binding doliculide causes premature senescence in p53 wild type cells / 24 (2) , 123
8	Claire J. Cairney. (2017) PLOS Genetics A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds / 13 (8) , e1006942
	John Tower. (2015) Ageing Research Reviews Programmed cell death in aging / 23 , 90
	Mantas Grigalavicius. (2017) Photodiagnosis and Photodynamic Therapy The influence of photodynamic therapy with 5-aminolevulinic acid on senescent skin cancer cells / 17 , 29
4	Dong-Min Yu. (2017) Aging Cell Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction / 16 (4) , 773
	Maria Widel. (2015) Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis The different radiation response and radiation-induced bystander effects in colorectal carcinoma cells differing in p53 status / 778 , 61
4	Sang Hyup Lee. (2016) Biochemical and Biophysical Research Communications CBX8 antagonizes the effect of Sirtinol on premature senescence through the AKT-RB-E2F1 pathway in K562 leukemia cells / 469 (4) , 884
	Anna Maria Mileo. (2016) Oxidative Medicine and Cellular Longevity Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies / 2016 , 1
3	S H Jung. (2016) Cell Death and Differentiation Heparan sulfation is essential for the prevention of cellular senescence / 23 (3) , 417
8	Rong-Jane Chen. (2017) Cell Death and Disease P53-dependent downregulation of hTERT protein expression and telomerase activity induces senescence in lung cancer cells as a result of pterostilbene treatment / 8 (8) , e2985
	Hossam Draz. (2017) Cellular Signalling Diindolylmethane and its halogenated derivatives induce protective autophagy in human prostate cancer cells via induction of the oncogenic protein AEG-1 and activation of AMP-activated protein kinase (AMPK) / 40 , 172
00219541	(2019) Journal of Cellular Physiology Trehalose inhibits cell proliferation and amplifies long-term temozolomide- and radiation-induced cytotoxicity in melanoma cells: A role for autophagy and premature senescence / (00219541)
1476-5594	(2019) Oncogene Radiation-promoted CDC6 protein stability contributes to radioresistance by regulating senescence and epithelial to mesenchymal transition / (1476-5594)
1476-5403	(2018) Cell Death & Differentiation Integrin α6β4-Src-AKT signaling induces cellular senescence by counteracting apoptosis in irradiated tumor cells and tissues / (1476-5403)
00063592	(2018) Biotechnology and Bioengineering 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs / (00063592)